Andreas D Braun
Overview
Explore the profile of Andreas D Braun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mengoni M, Mahlo F, Gaffal E, Tuting T, Braun A
Lab Invest
. 2024 Dec;
105(3):102209.
PMID: 39675722
The success of immune checkpoint inhibitors (ICI) in melanoma therapy has catalyzed the introduction of ICI in increasingly early stages of the disease. This exposes many patients with a lower...
2.
Mengoni M, Tuting T, Gaffal E, Braun A
Oncol Ther
. 2024 Dec;
13(1):131-143.
PMID: 39661321
Introduction: The introduction of immunotherapy (IT) has transformed clinical care of patients with metastatic melanoma. However, many patients still die as a result of progressive disease. Here we analyzed how...
3.
Hansen-Abeck I, Geidel G, Abeck F, Kott J, Cankaya R, Dobos G, et al.
J Dtsch Dermatol Ges
. 2024 Oct;
22(11):1489-1497.
PMID: 39358932
Background: Interferon-alpha is an important therapeutic option for the treatment of the cutaneous T-cell lymphomas (CTCL). Since the approved recombinant interferon-α-2a (IFN-α2a) has no longer been produced since January 2020,...
4.
Kruse B, Buzzai A, Shridhar N, Braun A, Gellert S, Knauth K, et al.
Nature
. 2023 Jun;
618(7967):1033-1040.
PMID: 37316667
Most clinically applied cancer immunotherapies rely on the ability of CD8 cytolytic T cells to directly recognize and kill tumour cells. These strategies are limited by the emergence of major...